Diabetes

April 22, 2019
Published by admin_auro at April 22, 2019
Categories

Mechanistic insights into how bariatric surgery aids in control of body weight, energy homeostasis, and TIIDM: Bariatric surgery increases REV-ERB and its downstream target genes, inhibits lipid accumulation, improves dyslipidemia and insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 22/April/2018, 11.35 pm

Introduction: What they say A study from the Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida 33458, USA shows that “Regulation of circadian behaviour […]
Do you like it?0
Read more
April 21, 2019
Published by admin_auro at April 21, 2019
Categories

Bariatric surgery for glucose homeostasis and TIIDM: Bariatric surgery increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 21/April/2019, 11.59 pm

Introduction: What they say A study from the Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, […]
Do you like it?0
Read more
April 21, 2019
Published by admin_auro at April 21, 2019
Categories

Mechanistic insights into how Bariatric surgery aids in remission of hyperglycemia: Bariatric surgery inhibits Amysin expression, increases insulin secretion, and decreases the risk of hyperglycemia via down regulation of  Sox4 and its target gene Amysin,  21/April/2017, 11.36 pm

Introduction: What they say  Nobel laureate in Physiology/Medicine (1975) Prof. David Baltimore and his research team, from California Institute of Technology, California, USA, had reported in the September 14, 2014 issue of […]
Do you like it?0
Read more
April 21, 2019
Published by admin_auro at April 21, 2019
Categories

Cyclic helix B peptide (CHBP)-based therapy for glucose homeostasis and TIIDM: Cyclic helix B peptide (CHBP)  increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM, via down regulation of its target gene, 21/April/2019, 10.44 pm

Introduction: What they say A study from the Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, […]
Do you like it?0
Read more
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104
Next page